Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets from genome-wide association studies of European subjects (n=2,764 cases and 10,475 controls) followed by validation genotyping in an independent cohort (n=3,716 cases and 4,261 controls). We discover and validate six previously unknown risk loci for PBC (Pcombined <5 × 10-8) and used pathway analysis to identify JAK-STAT/IL12/IL27 signalling and cytokine-cytokine pathways, for which relevant therapies exist.
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways / H.J. Cordell, Y.H.. - In: NATURE COMMUNICATIONS. - ISSN 2041-1723. - 6:(2015), pp. 8019.1-8019.11. [10.1038/ncomms9019]
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
A. Lleo;D. Cusi;J. Zhang;C. Barlassina;P.M. Battezzati;A. Benedetti;F. Bernuzzi;G. Casella;A. Colli;G. Elia;B. Foglieni;F. Malinverno;F. Marra;M. Podda;V. Ronca;M. Zuin;A. Dias;S. Levi;R. Jones;D. Jones;S. Campbell;A. Li;A. Bell;J. Jones;
2015
Abstract
Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets from genome-wide association studies of European subjects (n=2,764 cases and 10,475 controls) followed by validation genotyping in an independent cohort (n=3,716 cases and 4,261 controls). We discover and validate six previously unknown risk loci for PBC (Pcombined <5 × 10-8) and used pathway analysis to identify JAK-STAT/IL12/IL27 signalling and cytokine-cytokine pathways, for which relevant therapies exist.| File | Dimensione | Formato | |
|---|---|---|---|
|
ncomms9019.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
351.23 kB
Formato
Adobe PDF
|
351.23 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




